Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Major Histocompatibility Complex, Class II, DR beta 3 (HLA-DRB3) (C-Term) Peptide

HLA-DRB3 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN978026
  • Antigène Tous les produits HLA-DRB3
    HLA-DRB3 (Major Histocompatibility Complex, Class II, DR beta 3 (HLA-DRB3))
    Protein Region
    C-Term
    Origine
    Humain
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Séquence
    GFYPGSIEVR WFRNGQEEKA GVVSTGLIQN GDWTFQTLVM LETVPRSGEV
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-HLA-DRB3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    HLA-DRB3 (Major Histocompatibility Complex, Class II, DR beta 3 (HLA-DRB3))
    Synonymes
    HLA-DR3B Peptide, BLA-DRB3 Peptide, Bota-DRB01 Peptide, Bota-DRB02 Peptide, Bota-DRB04 Peptide, Bota-DRB07 Peptide, Bota-DRB21 Peptide, Bota-DRB22 Peptide, LA-DRB Peptide, major histocompatibility complex, class II, DR beta 3 Peptide, major histocompatibility complex, class II, DRB3 Peptide, HLA-DRB3 Peptide, BOLA-DRB3 Peptide
    Sujet
    HLA-DRB3 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. The presence of DRB3 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.

    Alias Symbols: HLA-DR3B, HLA-DR52, HLA-DRB1, MGC117330

    Protein Interaction Partner: CTAG1B,POMC,POMC

    Protein Size: 266
    Poids moléculaire
    27 kDa
    ID gène
    3125
    NCBI Accession
    NM_022555, NP_072049
    UniProt
    P13762
Vous êtes ici:
Support technique